Morepen Laboratories Ltd Share Price

Overview

Morepen Laboratories Ltd share price is currently ₹94.02, down by - ₹1.13 (1.19%) from its previous closing price of ₹95.15. The share price has gained 77.53% over the past month and gained 62.27% over the past year. The stock's 52-week low and high are ₹32.38 and ₹96.86, respectively. Morepen Laboratories Ltd has a market capitalisation of ₹ 5,260.00 Cr. The share price was last updated on 24 Aug 2026, 03:59 PM IST.

Morepen Laboratories Ltd

MOREPENLAB

₹0.00

- ₹1.13

1.19%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:59:21 pm IST

Market Data

Open Price

₹94.55

Prev. Close

₹95.15

₹93.26

Day Low

₹95.62

Day High

₹32.38

52 Week Low

₹96.86

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

36.73

Sector PE

42.03

PB Ratio

4.46

Sector PB

5.82

EPS

2.56

Dividend Yield

0.42

Today's Volume

17.609 M

5 Day Avg. Volume

27.011 M

PEG Ratio

2.53

Market Cap.

₹ 5,260.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 10% at ₹0.2/Share	18-Sep-2026	19-Sep-2026
DividendsFinal Dividend of 10% at ₹0.2/Share	29-Aug-2025	30-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Motilal Oswal BSE Healthcare ETF	9.25 k	9.46 k (2.17%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth	4.74 k	5.08 k (7.09%)
Motilal Oswal BSE 1000 Index Fund - Regular Plan - Growth	1.04 k	1.02 k (1.73%)

About Morepen Laboratories Ltd 👋

Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Linagliptin, Linagliptin + Metformin, Empagliflozin, Empagliflozin + Metformin, Atorvastatin, Rosuvastain, Rivaroxaban, Fexofenadine, Montelukast (Oral), Montelukast (Chewable), Montelukast Sodium, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen Nebulizer Model CN-11, Dr. Morepen Pulse Oximeter Model PO-12A, Dr. Morepen Breathe Free Vaporizer Model VP-06 and Dr. Morepen Pulse Oximeter Model PO-12A, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.